Skip to main content

Table 2 Comparison of dose to PTVs calculated using AAA and AXB for all patients

From: Clinical implication in the use of the AAA algorithm versus the AXB in nasopharyngeal carcinomas by comparison of TCP and NTCP values

Target (dose metric)

Median dose [min,max] in Gy

p

AAA

AXB

PTV1(D95%)

66.8 [64.1,69.1]

65.8 [62.9,68.3]

< 0.001

PTV1(D2%)

72.7 [70.6,73.6]

72.0 [70.0,73.2]

< 0.001

PTV1(Dmean)

70.2 [68.1,71.1]

69.5 [67.3,70.9]

< 0.001

PTV2(D95%)

58.1 [53.0,64.5]

57.9 [54.8,65.6]

0.310

PTV2(D2%)

66.0 [62.1,70.7]

65.6 [61.5,70.2]

0.008

PTV2(Dmean)

61.3 [57.9,68.0]

60.8 [57.6,67.3]

< 0.001

PTV3(D95%)

52.4 [50.4,56.6]

52.1 [50.1,56.4]

0.266

PTV3(D2%)

58.9 [55.5,71.3]

58.8 [55.7,69.8]

0.03

PTV3(Dmean)

55.1 [52.8,61.0]

54.66 [52.7,60.4]

< 0.001

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us